Advertisement

Reactions Weekly

, Volume 1736, Issue 1, pp 104–104 | Cite as

Erlotinib/osimertinib

Interstitial lung disease and acquired resistance in lung adenocarcinoma: case report
Case report
  • 18 Downloads

Reference

  1. Deng S-M, et al. Fatal interstitial lung disease associated with AZD9291. Journal of Cancer Research and Therapeutics 14: S1227-S1229, No. 12, 2018. Available from: URL: http://doi.org/10.4103/0973-1482.199380 - China

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations